4//SEC Filing
Heyman Irwin A 4
Accession 0001104659-11-018559
CIK 0001411158other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 7:33 PM ET
Size
5.4 KB
Accession
0001104659-11-018559
Insider Transaction Report
Form 4
Heyman Irwin A
Senior VP Product Development
Transactions
- Award
Stock Option (right to buy)
2011-03-31+52,900→ 52,900 totalExercise: $6.92Exp: 2021-03-30→ Common Stock (52,900 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the option shall vest and become exercisable on the 12 month anniversary of the Vesting Commencement Date and 1/48 of the shares subject to the option shall vest and become exercisable on each monthly anniversary thereafter. Vesting Commencement Date is January 1, 2011.
Documents
Issuer
Anacor Pharmaceuticals Inc
CIK 0001411158
Entity typeother
Related Parties
1- filerCIK 0001504369
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 7:33 PM ET
- Size
- 5.4 KB